Uppsala Clinical Research Center, Sweden
Disclosure information not submitted.
Emulating a target trial to avoid immortal time-bias in the estimation of PCSK9 inhibitor effects post myocardial infarction: Methodological opportunities and challenges
Monday, August 26, 20241:30 PM – 1:45 PM CEST
